Lithuania received 1,400 doses of the „Jynneos“ vaccine, which the European Commission bought and proportionately distributed to the Member States of the European Union.

Mass vaccination of the population against monkeypox is not carried out, only those persons who had high-risk contact with the sick person can be vaccinated. Such individuals are identified by specialists of the National Public Health Center (NVSC) by interviewing a patient with monkeypox. After assessing the degree of risk, NVSC specialists can recommend immunoprophylaxis and refer to one of the five vaccinating institutions (Vilnius, Kaunas, Klaipėda, Šiauliai or Panevėžys). The doctor of the vaccinating institution will assess the health status of the person who had contact and make the final decision on vaccination.

Persons from the age of 18 years can be vaccinated with the „Jynneos“ vaccine. The vaccination schedule consists of two doses administered 4 weeks apart. Individuals who have previously received one dose of live smallpox vaccine are recommended to receive another dose of the vaccine.